Evidence map›Paper›PMID 41158494›Full record

ArticleERJ open research2025

Is

Adèle Sandot, Ibrahima Ba, Clément R Massonnaud, Raphaël Borie, Benjamin Renaud-Picard, Benjamin Coiffard, Xavier Demant, Loïc Falque, Antoine Roux, Jérôme Le Pavec and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Adèle SandotUniversité Paris Cité, PHERE UMRS 1152, Paris, France.
Ibrahima BaUniversité Paris Cité, PHERE UMRS 1152, Paris, France.
Clément R MassonnaudUniversité Paris Cité, Inserm, IAME, Paris, France.
Raphaël BorieUniversité Paris Cité, PHERE UMRS 1152, Paris, France.ORCID https://orcid.org/0000-0002-9906-0024
Benjamin Renaud-PicardDepartment of Respiratory Medicine and Strasbourg Lung Transplant Program, Inserm UMR 1260, Université de Strasbourg, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.ORCID https://orcid.org/0000-0003-3492-9486
Benjamin CoiffardDepartment of Respiratory Medicine and Lung Transplantation, APHM, Hôpital Nord, Aix Marseille Univ, Marseille, France.
Xavier DemantService de Pneumologie, Centre Hospitalier Universitaire de Bordeaux, Pessac, France.
Loïc FalqueService Hospitalier Universitaire de Pneumologie et Physiologie, CHU Grenoble Alpes, Pôle Thorax et Vaisseaux, Grenoble, France.
Antoine RouxPneumology, Adult Cystic Fibrosis Center and Lung Transplantation Department, Foch Hospital, Suresnes, France.
Jérôme Le PavecService de Pneumologie et Transplantation Pulmonaire, Groupe hospitalier Marie-Lannelongue-Saint Joseph, Le Plessis-Robinson, France.
Adrien TissotCHU Nantes, INSERM, Service de Pneumologie, Institut du thorax, Center for Research in Transplantation and Translational Immunology (CR2TI), UMR 1064, Nantes Université, Nantes, France.ORCID https://orcid.org/0000-0002-3259-6430
Claire MerveilleuxUniversité Lyon 1, PSL, EPHE, INRAE, IVPC, Hospices Civils de Lyon, Groupement Hospitalier Est, Service de Pneumologie, Orphalung, RESPIFIL, Université de Lyon, Lyon, France.
Thomas VilleneuveCHU Toulouse, Service de Pneumologie, Université Toulouse III-Paul Sabatier, Toulouse, France.ORCID https://orcid.org/0000-0002-1947-3401
Christiane KnoopService de Pneumologie, CHU Erasme, Brussels, Belgium.
Vincent BunelUniversité Paris Cité, PHERE UMRS 1152, Paris, France.
Nicolas CarlierAPHP, Service de Pneumologie, Hôpital Cochin, Paris, France.ORCID https://orcid.org/0000-0002-6828-608X
David LairCHU Nantes, Nantes Université, Institut du Thorax, Lung O2, Nantes, France.ORCID https://orcid.org/0000-0002-9309-6018
Pierre MordantUniversité Paris Cité, PHERE UMRS 1152, Paris, France.
Caroline KannengiesserUniversité Paris Cité, PHERE UMRS 1152, Paris, France.ORCID https://orcid.org/0000-0003-2155-9383
Jonathan MessikaUniversité Paris Cité, PHERE UMRS 1152, Paris, France.ORCID https://orcid.org/0000-0003-2123-3527
COLT consortium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic lung allograft dysfunction (CLAD) is the main cause of death following lung transplantation (LT). Its pathophysiology and risk factors remain poorly understood. Donor or recipient genetic characteristics could be involved. Methods: Recipient and donor blood samples from the Cohort in Lung Transplantation biobank were used. Results: 210 recipient-donor pairs were analysed. At 5 years, 68 patients (32.4%) had CLAD. The Conclusion:

Identifiers

PMID41158494
PMCPMC12557440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.